Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook

血脂异常 医学 内科学 剩余风险 胆固醇 风险因素 代谢综合征 脂蛋白 内分泌学 糖尿病 甘油三酯 肥胖
作者
Vikrama Raja,Carlos Aguíar,Nasreen Al-Sayed,Yogeyaa S. Chibber,Hussein ElBadawi,М. В. Ежов,Michel P. Hermans,Ramesh C. Pandey,Kausik K. Ray,Lâle Tokgözoğlu,Alberto Zambon,Jean‐Pascal Berrou,Michel Farnier
出处
期刊:Atherosclerosis [Elsevier BV]
卷期号:383: 117312-117312 被引量:95
标识
DOI:10.1016/j.atherosclerosis.2023.117312
摘要

Dyslipidemia refers to unhealthy changes in blood lipid composition and is a risk factor for atherosclerotic cardiovascular diseases (ASCVD). Usually, low-density lipoprotein-cholesterol (LDL-C) is the primary goal for dyslipidemia management. However, non-high-density lipoprotein cholesterol (non-HDL-C) has gained attention as an alternative, reliable goal. It encompasses all plasma lipoproteins like LDL, triglyceride-rich lipoproteins (TRL), TRL-remnants, and lipoprotein a [Lp(a)] except high-density lipoproteins (HDL). In addition to LDL-C, several other constituents of non-HDL-C have been reported to be atherogenic, aiding the pathophysiology of atherosclerosis. They are acknowledged as contributors to residual ASCVD risk that exists in patients on statin therapy with controlled LDL-C levels. Therefore, non-HDL-C is now considered an independent risk factor or predictor for CVD. The popularity of non-HDL-C is attributed to its ease of estimation and non-dependency on fasting status. It is also better at predicting ASCVD risk in patients on statin therapy, and/or in those with obesity, diabetes, and metabolic disorders. In addition, large follow-up studies have reported that individuals with higher baseline non-HDL-C at a younger age (<45 years) were more prone to adverse CVD events at an older age, suggesting a predictive ability of non-HDL-C over the long term. Consequently, non-HDL-C is recommended as a secondary goal for dyslipidemia management by most international guidelines. Intriguingly, geographical patterns in recent epidemiological studies showed remarkably high non-HDL-C attributable mortality in high-risk countries. This review highlights the independent role of non-HDL-C in ASCVD pathogenesis and prognosis. In addition, the need for a country-specific approach to dyslipidemia management at the community/population level is discussed. Overall, non-HDL-C can become a co-primary or primary goal in dyslipidemia management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Owen应助BSDL采纳,获得10
刚刚
香蕉觅云应助EmmaLin采纳,获得10
刚刚
刚刚
4秒前
田様应助lzh采纳,获得10
6秒前
6秒前
7秒前
科研通AI5应助钟D摆采纳,获得10
8秒前
科研小狗发布了新的文献求助10
8秒前
哈基米德应助科研通管家采纳,获得20
8秒前
9秒前
yyy关闭了yyy文献求助
9秒前
香蕉觅云应助科研通管家采纳,获得10
9秒前
laber应助科研通管家采纳,获得50
9秒前
英俊的铭应助科研通管家采纳,获得10
9秒前
科研通AI6应助科研通管家采纳,获得150
9秒前
Hello应助科研通管家采纳,获得10
9秒前
蜀安应助科研通管家采纳,获得200
9秒前
17764715645应助科研通管家采纳,获得20
10秒前
星辰大海应助科研通管家采纳,获得10
10秒前
隐形曼青应助科研通管家采纳,获得10
10秒前
科研通AI6应助科研通管家采纳,获得150
10秒前
华仔应助科研通管家采纳,获得10
10秒前
科目三应助科研通管家采纳,获得10
10秒前
科研通AI5应助科研通管家采纳,获得10
10秒前
科研通AI5应助科研通管家采纳,获得10
10秒前
哈基米德应助科研通管家采纳,获得20
10秒前
uni发布了新的文献求助10
11秒前
11秒前
耍酷乌完成签到,获得积分10
11秒前
aha关注了科研通微信公众号
12秒前
666发布了新的文献求助10
12秒前
13秒前
14秒前
una完成签到 ,获得积分10
15秒前
15秒前
16秒前
拓跋子轩完成签到,获得积分10
17秒前
pluto完成签到 ,获得积分10
18秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
A Half Century of the Sonogashira Reaction 1000
Artificial Intelligence driven Materials Design 600
Investigation the picking techniques for developing and improving the mechanical harvesting of citrus 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 500
A Manual for the Identification of Plant Seeds and Fruits : Second revised edition 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5191054
求助须知:如何正确求助?哪些是违规求助? 4374552
关于积分的说明 13621498
捐赠科研通 4228481
什么是DOI,文献DOI怎么找? 2319295
邀请新用户注册赠送积分活动 1317858
关于科研通互助平台的介绍 1267898